Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio

Ping An Biomedical (NASDAQ: PASW) signs LOI to acquire 3 tumor cell-related patents for $2–2.5M to build a core oncology and biotech IP portfolio.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.